Filter Results:
(324)
Show Results For
- All HBS Web (324)
- Faculty Publications (138)
Show Results For
- All HBS Web (324)
- Faculty Publications (138)
- May 2012 (Revised August 2014)
- Case
McKesson
By: Regina E. Herzlinger and Natalie Kindred
McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010 revenues, just made its first foray into... View Details
Keywords: Health Care Industry; Health Care Policy; Organizational Transformations; Health Services; Health Care and Treatment; Business Model; Service Operations; Change Management; Corporate Strategy; Information Technology; Policy; Pharmaceutical Industry; Health Industry; United States
Herzlinger, Regina E., and Natalie Kindred. "McKesson." Harvard Business School Case 312-002, May 2012. (Revised August 2014.)
- 15 Jul 2013
- Research & Ideas
Five Imperatives for Improving Health Care
Innovation in health care treatment seems to far outpace innovation in health care business management. Just ask President Obama—two weeks ago he delayed enactment of a key provision of the new health care law for fear its requirements... View Details
- 19 Dec 2017
- First Look
New Research and Ideas, December 19, 2017
integration into receiving countries. In this study, 23,800 citizens were randomly assigned to receive visits from political activists during the lead-up to the 2010 French regional elections. Treatment increased the turnout of immigrants... View Details
Keywords: Carmen Nobel
- Article
Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries
By: Ariel Dora Stern, William J. Gordon, Adam B. Landman and Daniel B. Kramer
Objectives:
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
Keywords: Digital; Medicine; FDA; Health Care and Treatment; Applications and Software; Safety; Cybersecurity; Medical Devices and Supplies Industry
Stern, Ariel Dora, William J. Gordon, Adam B. Landman, and Daniel B. Kramer. "Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries." BMJ Open 9, no. 6 (June 2019).
- 07 Feb 2024
- News
The Sound of Success
A groundbreaking gene therapy developed by Akouos, Inc., a precision genetic medicine company founded in 2016 by Emmanuel (Manny) Simons (MBA 2012), has enabled an 11-year-old boy from Morocco to hear sounds for the first time. According to a recent New York Times... View Details
- 04 Apr 2024
- News
The Making of a Medical Milestone
first discovered at the ALS Therapy Development Institute and in part funded by the ALS Ice Bucket Challenge. The drug shows promise as a treatment for neurological diseases like ALS in addition to organ... View Details
Keywords: Margie Kelley
- 30 May 2024
- Research & Ideas
Racial Bias Might Be Infecting Patient Portals. Can AI Help?
differences in response to different types of customers,” Stern says. “To the extent those exist, that means you’re not serving a certain group of customers, and you’re potentially leaving money on the table.” You Might Also Like: The FDA’s Speedy View Details
- 13 Jul 2023
- News
The Network Effect
deal included $1.8 billion in cash, plus a potential future $200 million milestone payment for a clinical-stage drug to treat brain cancer and a 5 percent royalty on the US sales of Tibsovo, a drug used to... View Details
- 14 Jul 2023
- Blog Post
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows
industries, including: a novel enzymatic RNA synthesis platform, an immune system-driven dendritic cell therapy to combat cancer, new molecular technologies for the delivery of transdermal formulations, a lipid-targeting drug to treat... View Details
- 30 Jun 2022
- News
Scaling Hope
programs of treatment providers like Hazelden Betty Ford and Caron Treatment Centers. His ultimate message is one of hope. That’s what he didn’t know in the beginning: “I wish I had known that there was... View Details
- 26 Jan 2024
- Blog Post
HBS Alumna Fighting Cancer with a Novel Cell Therapy
and will call myself an engineer forever. But I recognized that my strengths and experiences are well suited for the business side of drug development.” Guardian Bio’s cell therapy uses dendritic cells, an essential component in the human... View Details
- Web
Winners & Runners-Up | New Venture Competition
Venture Competition Runner-Up, Business Track: Sanso Sanso is helping drug manufacturers produce life-saving biologics more efficiently, in order to deliver cheaper drugs to patients worldwide. Team: Narek... View Details
- Web
Skydeck - Alumni
revolutionize drug development along the way Bridging the Gap Global Citizen Year founder Abby Falik (MBA 2008) on why kids need to find their purpose before freshman year Cold Call Horror Stories Alumni relive the School's most... View Details
- 22 Nov 2004
- Research & Ideas
Side Effects: The Case of Propecia
You are the marketing director of Propecia, a new drug for hair restoration that's about to hit the market. But the drug can only be purchased via a physician's prescription. So do you advertise directly to... View Details
- 31 Jan 2014
- News
Body, Heal Thyself
messenger RNA (mRNA) Therapeutics. The data that Bancel saw that evening were shocking. The numbers suggested Moderna had found an entirely new way to treat diseases—one that promised to change the medical world, resulting in cures for rare diseases and View Details
- 31 Mar 2023
- Research & Ideas
Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?
Professor of Public Policy at Harvard’s John F. Kennedy School of Government, conducted the research with Katherine Baicker of the University of Chicago and Mark Shepard, associate professor of public policy at the Kennedy School. Addressing the high costs of health... View Details
- Web
Rare Disease Day – Small Numbers, Big Challenges… and Big Opportunities - Blog: Health Supplement
disorder immediately. HHT has no cure or FDA approved treatment yet, and severe complications can arise if it is not properly diagnosed or treated. People living with rare diseases, like HHT, suffer from increased mortality and reduced... View Details
- 22 Aug 2005
- Research & Ideas
The Hard Work of Failure Analysis
analyzing failure benefit in two ways. First, analyzing a failed drug sometimes reveals that the drug may have a viable alternate use. For example, Pfizer's Viagra was originally designed to be a View Details
Keywords: by Amy Edmondson & Mark D. Cannon
- 01 Jun 2023
- News
From Big Pharma to Startup
the life cycle of the company”—from proof of concept to platform and product development. It plans to focus first on creating oral versions of peptide hormone drugs used to treat rare endocrine and metabolic diseases. Although Goble is no... View Details
Keywords: April White
- 25 Aug 2003
- Research & Ideas
Why IT Does Matter
Radio-frequency identification devices for grocery stores, smart cards, and automated ordering systems for hospital physicians are all examples of new process targets that technologies will soon address. In the more distant future we will see the improved creation of... View Details
Keywords: by F. Warren McFarlan & Richard L. Nolan